A two-arm multicenter phase II trial of one cycle chemoselection split-dose docetaxel, cisplatin and 5-fluorouracil (TPF) induction chemotherapy before two cycles of split TPF followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1)
Inhestern J, Schmalenberg H, Dietz A, Rotter N, Maschmeyer G, Jungehülsing M, Grosse-Thie C, Kuhnt T, Görner M, Sudhoff H, Wittekindt C, et al. (2017)
Annals of Oncology 28(8): 1917-1922.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Inhestern, J.;
Schmalenberg, H.;
Dietz, A.;
Rotter, N.;
Maschmeyer, G.;
Jungehülsing, M.;
Grosse-Thie, C.;
Kuhnt, T.;
Görner, M.;
Sudhoff, HolgerUniBi
;
Wittekindt, C.;
Guntinas-Lichius, O.
Alle
![](https://pub.uni-bielefeld.de/images/icon_orcid.png)
Alle
Erscheinungsjahr
2017
Zeitschriftentitel
Annals of Oncology
Band
28
Ausgabe
8
Seite(n)
1917-1922
ISSN
0923-7534
Page URI
https://pub.uni-bielefeld.de/record/2951850
Zitieren
Inhestern J, Schmalenberg H, Dietz A, et al. A two-arm multicenter phase II trial of one cycle chemoselection split-dose docetaxel, cisplatin and 5-fluorouracil (TPF) induction chemotherapy before two cycles of split TPF followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1). Annals of Oncology. 2017;28(8):1917-1922.
Inhestern, J., Schmalenberg, H., Dietz, A., Rotter, N., Maschmeyer, G., Jungehülsing, M., Grosse-Thie, C., et al. (2017). A two-arm multicenter phase II trial of one cycle chemoselection split-dose docetaxel, cisplatin and 5-fluorouracil (TPF) induction chemotherapy before two cycles of split TPF followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1). Annals of Oncology, 28(8), 1917-1922. https://doi.org/10.1093/annonc/mdx202
Inhestern, J., Schmalenberg, H., Dietz, A., Rotter, N., Maschmeyer, G., Jungehülsing, M., Grosse-Thie, C., et al. 2017. “A two-arm multicenter phase II trial of one cycle chemoselection split-dose docetaxel, cisplatin and 5-fluorouracil (TPF) induction chemotherapy before two cycles of split TPF followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1)”. Annals of Oncology 28 (8): 1917-1922.
Inhestern, J., Schmalenberg, H., Dietz, A., Rotter, N., Maschmeyer, G., Jungehülsing, M., Grosse-Thie, C., Kuhnt, T., Görner, M., Sudhoff, H., et al. (2017). A two-arm multicenter phase II trial of one cycle chemoselection split-dose docetaxel, cisplatin and 5-fluorouracil (TPF) induction chemotherapy before two cycles of split TPF followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1). Annals of Oncology 28, 1917-1922.
Inhestern, J., et al., 2017. A two-arm multicenter phase II trial of one cycle chemoselection split-dose docetaxel, cisplatin and 5-fluorouracil (TPF) induction chemotherapy before two cycles of split TPF followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1). Annals of Oncology, 28(8), p 1917-1922.
J. Inhestern, et al., “A two-arm multicenter phase II trial of one cycle chemoselection split-dose docetaxel, cisplatin and 5-fluorouracil (TPF) induction chemotherapy before two cycles of split TPF followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1)”, Annals of Oncology, vol. 28, 2017, pp. 1917-1922.
Inhestern, J., Schmalenberg, H., Dietz, A., Rotter, N., Maschmeyer, G., Jungehülsing, M., Grosse-Thie, C., Kuhnt, T., Görner, M., Sudhoff, H., Wittekindt, C., Guntinas-Lichius, O.: A two-arm multicenter phase II trial of one cycle chemoselection split-dose docetaxel, cisplatin and 5-fluorouracil (TPF) induction chemotherapy before two cycles of split TPF followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1). Annals of Oncology. 28, 1917-1922 (2017).
Inhestern, J., Schmalenberg, H., Dietz, A., Rotter, N., Maschmeyer, G., Jungehülsing, M., Grosse-Thie, C., Kuhnt, T., Görner, M., Sudhoff, Holger, Wittekindt, C., and Guntinas-Lichius, O. “A two-arm multicenter phase II trial of one cycle chemoselection split-dose docetaxel, cisplatin and 5-fluorouracil (TPF) induction chemotherapy before two cycles of split TPF followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1)”. Annals of Oncology 28.8 (2017): 1917-1922.
Daten bereitgestellt von European Bioinformatics Institute (EBI)
Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
References
Daten bereitgestellt von Europe PubMed Central.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 28498880
PubMed | Europe PMC
Suchen in